{
    "2018-06-15": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Teva Scraps A Study In Cluster Headaches â€” And This Rival Benefits",
                "features": {
                    "keywords": [
                        "Teva",
                        "scraps",
                        "study",
                        "cluster headaches",
                        "rival benefits"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "LLY",
                        "AZN",
                        "Alzheimer's",
                        "drug fails",
                        "MRK",
                        "Keytruda",
                        "wins approvals"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "LLY",
                        "AZN",
                        "Alzheimer's",
                        "drug fails",
                        "MRK",
                        "Keytruda",
                        "wins approvals"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}